Clinical Trial Update: A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Fluzoparib with or without Apatinib versus placebo for maintenance in advanced ovarian cancer after response to first-line platinum-bas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Fluzoparib (fluzoparib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: UNKNOWN